1 results
24/May/2022
24/May/2022
DOI: 10.31744/einstein_journal/2022AO6985
ABSTRACT Objective: To determine the association of red cell blood counts, and liver panel tests to predict outcomes in patients with gastroenteropancreatic neuroendocrine tumors who underwent systemic antineoplastic treatments. Methods: Patients with gastroenteropancreatic neuroendocrine tumors in systemic treatment were assessed according to laboratory tests within the same period. Progression free survival was determined by the period between the beginning of treatment and the date of progression. We used conditional models (PWP model) to verify the association between laboratory tests and […]
Keywords: Biomarkers; Blood platelets; Chromogranin A; Gastro-enteropancreatic neuroendocrine tumor; Intention to treat analysis; Lutetium; Neuroendocrine tumors; Neutrophils